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Accepted 15 March 2012AbstractObjective: Curcuminoids (including curcumin) are natural antioxidants demonstrating potent chemopreventive properties against several forms
of cancer. This study investigated the antiproliferative and induced apoptotic effects of curcuminoids on three cell lines isolated from human
breast adenocarcinoma and ductal carcinoma (MDA-MB-231, MDA-MB-435S, and MCF-7).
Materials and Methods: This study developed a highly sensitive, reproducible assay method using high-pressure liquid chromatography to
quantify the cellular uptake of curcuminoids by breast cancer cells and quantitate its effect on inhibition of proliferation and activation of
apoptosis in breast cancer cells.
Results: Results indicate that curcuminoids inhibited cell proliferation and activation of apoptosis in the cell lines in this study. Both effects were
observed to increase in proportion to the cellular uptake of curcuminoids; cellular uptake increased following an increase in the dosage of
curcuminoids.
Conclusion: The inhibition of proliferation and increased apoptosis of breast cancer cells appears to be associated with the uptake of curcu-
minoids by cancer cells.
Copyright  2012, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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Turmeric (a curcuminoid) is a herb isolated from the
rhizome of Curcuma longa. It is a popular spice in oriental
dishes such as curry and a drug found in traditional medicines
throughout Asia [1e3]. Turmeric has attracted considerable
interest in recent years due to its putative health benefits as an
antioxidant [4] and anti-inflammatory [5] agent, as well as for
its treatment potential in the prevention of cancer [6,7].* Corresponding author. Number 396, Sector 1, Changrong Road, Gueiren
District, Tainan City 71101, Taiwan.
E-mail addresses: d8702008@tmu.edu.tw, jenway@mail.cjcu.edu.tw (Y.-
C. Hsu).
1028-4559/$ - see front matter Copyright  2012, Taiwan Association of Obstetri
http://dx.doi.org/10.1016/j.tjog.2012.07.009A variety of mechanisms have been proposed to explain the
anticarcinogenic activity of curcuminoids: antioxidizing and
anti-inflammatory properties, induction of phase II detoxifi-
cation enzymes, inhibition of cyclooxygenase 2, an influence
on the transcription factors activator protein 1 (AP-1) and
nuclear factor kappa B, inhibition of matrix metalloproteinase,
and effects on protein kinases as well as other effects [8,9].
This study investigates the inhibition of cell proliferation and
the induction of apoptosis by curcumin to gain insight into the
underlying mechanisms associated with the chemopreventive
effects of curcuminoids.
Most of the various methods used for the detection and
analysis of curcuminoids involve the use of spectrophotometry
to characterize the yellow color in the samples [10e12].
Commercially available products are generally a mixture ofcs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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(DMC) and bisdemethoxycurcumin (bDMC). Researchers
have been unable to quantify the individual components of
curcuminoids using spectrophotometric methods; however,
liquid chromatographyemass spectrophotometry and radio-
labeling have recently been successfully applied to the
detection of curcumin [13e15].
This paper reports an investigation into whether curcumi-
noids contribute to antiproliferation and apoptosis in human
breast cancer cell lines: two of breast adenocarcinoma and one
of ductal carcinoma. We also sought to determine whether
these effects could be explained qualitatively and quantita-
tively, according to the bioavailability of the curcuminoids. To
achieve this, we developed a highly sensitive, reproducible
assay method using high-pressure liquid chromatography
(HPLC) to quantify the cellular uptake of curcuminoids by
breast cancer cells.
Materials and methodsCell lines and culture conditionsThe cell lines used in this series of investigations e MDA-
MB-435S (a metastatic human ductal carcinoma with no
tumorigenic in nude mice; ATCC HTB-129), MDA-MB-231
(a poorly differentiated human breast adenocarcinoma grade
III, with extracellular growth factor receptors, transforming
growth factor alpha receptors, and WNT7B oncogene expres-
sion, with tumorigenic in nude mice; ATCC HTB-26) and
MCF-7 (a human breast adenocarcinoma, with estrogen
receptors and WNT7B oncogene expression; ATCC HTB-22)
e were obtained from ATCC (Manassa, VA, USA) and
maintained in culture medium (GibcoBRL ,USA) based on the
specifications provided by ATCC. The medium was supple-
mented with 10e15% (v/v) fetal bovine serum (HyClone,
Logan, UT, USA) and a combination of antibiotics (HyClone)
with or without an atmosphere of carbon dioxide/air (5%).Assay of cell proliferationThe proliferation of the breast cancer cell lines after
exposure to curcuminoids was measured by the CellTiter96
AQueous One Solution Cell Proliferation Assay kit (Promega,
Madison, WI, USA). Briefly, the cells were first incubated
with curcuminoids for 24 hours and then treated with MTS [3-
(4,5-dimethyl-thiazol-2-yl)-5-(3-carboxymeth- oxy-phenyl)-2-
(4-sulfo-phenyl)-2H-tetrazolium] for 4 hours. Absorbance was
determined using a PowerWave XS Reader (Bio-tek, VT,
USA) at 490 nm. Each assay was carried out in triplicate and
the results were expressed as the mean  standard error of the
mean (SEM). Cell proliferation was expressed as the
percentage of the assay data determined for the control group.Assay of cell apoptosisThe apoptosis was assessed by the APOPercentage
Apoptosis Assay kit (Biocolor Ltd., Carrickfergus, Antrim,UK) and Annexin V-FITC Apoptosis Detection Kit (Strong
Biotech, Taipei, Taiwan). Briefly, the breast cancer cells
(5  104) were seeded in the culture medium, which contained
100 mL of serum, and dispensed into 96-well microplates.
After the culture medium had been treated with curcuminoids
for 24 hours, it was replaced with a fresh medium plus the
APOPercentage Dye Label. The APOP% Dye Release
Reagent was then added to each well to aid cell lysis and the
release of bound dye from the apoptotic cells. The amount of
the cell-bound dye recovered in the solution was measured
using the PowerWave XS Reader. A reference wavelength of
655 nm was used to estimate the apoptotic index at the
wavelength of 550 nm. Each assay was carried out in tripli-
cate, and the results were expressed as the mean  SEM of the
absorption at 550 nm.
The apoptotic cells were also detected using an Annexin
V-FITC Apoptosis Detection Kit and inspected by a Fluores-
cence Microscopy CKX41 and U-RFLT 50 (Olympus,
Australia). The filter for FITC was BA520 IF (BP460-490C)
and propidium iodide was BA590 (BP480-550C).Evaluation of mitochondrial membrane potentialThe breast cancer cells were first seeded in 24-well plates
(Orange Scientific, CA, USA) for 16e24 hours. Following
treatment with curcuminoids, rhodamine 123 (10 mg/mL;
Sigma, CA, USA) was added to the culture medium, 50 mL per
well, and then incubated (at 37 C for 20 minutes) for mito-
chondrial staining. After washing twice with warm phosphate
buffered saline, the cells were fixed with 2% para-
formaldehyde and inspected using fluorescence microscopy
(Olympus CKX41 and U-RFLT 50).Recovery of curcuminoids from breast cancer cells for
assayThe cell pellets were each suspended in the RIPA buffer
[20 mM Tris/HCl (at pH 8.0), 5 mM EDTA, 1 mM
phenylmethyl-sulfonyl fluoride, 1.5 mg leupeptin, 137 mM
NaCl, 10% (v/v) Glycerol, and protease inhibitor cocktail], and
celleliquid extraction was then carried out immediately. The
cell extracts were centrifuged at 14,000 g for 15minutes, and the
amounts of total cellular protein in the extracts were determined
using the Bradford method (Bio-Rad, CA, USA). The cell
extract obtained was acidified, 100 mL each, using 6 N HCl (1:1
w/v) and vortexed for 30 seconds. A further volume of
extracting solution (500 mL) was then added to each of the
acidified cell extracts. Samples were again centrifuged and then
shaken in the Orbited shaker (Heng-Chen, Kaohsiung, Taiwan)
(at 100 rpm) for 15 minutes. After centrifugation at 18,000 rpm
for 20 minutes, the upper organic layer was filtered using
a membrane filter (0.22 mm) and transferred to a clean injection
sample vial (approximately 100 mL) for a quantitative analysis
using the Recovery curcuminoids and high performance liquid
chromatography (HPLC) methods previously described [7].
A Hitachi L-2000 series HPLC system (Hitachi, Osaka,
Japan) was used to carry out the HPLC analysis of
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2130 model) equipped with a fluorescence detector (L-2480
model), an autosampler (L-2130 model), and a reversed-phase
column (Purospher STAR RP-18e, 5mM; Merck, NJ , USA)
maintained at 37 C by a column oven (L-2350 model). A
mobile phase, which was composed of acetic acid (2%) pH 2.5
and acetonitrile (in a ratio of 47:53) and delivered at a flow
rate of 0.8 mL/min, was used, while the samples were each
injected with an injection volume of 20 mL. With the use of an
excitation wavelength of 420 nm and an emission wavelength
of 540 nm, curcumin, DMC, and bDMC were detected [7].Statistical analysisFig. 1. Inhibitory effect of curcuminoids on the survival/proliferation of human
breast cancer cells. (A) Three lines of human breast cancer cells (MDA-MB-
231, MDA-MB-435S, and MCF-7) were used in the study. The cell lines were
each treated with an increasing dose (0, 12.5, 25, and 50 mM) of curcuminoids
(n ¼ 6 for each study group), and the levels of survival and proliferation were
assessed by MTS assay. The solid bars (MDA-MB-231 cells), hatched bars
(MDA-MB-435S cells), and open bars (MCF-7 cells) represent the levels of
cell survival and proliferation, as a percentage of the control values (controls
being treated with 0 mM curcuminoids). (B, C) Apoptosis of breast cancer cells
in the three cell lines (MDA-MB-231, MDA-MB-435S, and MCF-7) induced
by curcuminoid treatment was determined using the APO PercentageAll data are reported as the mean  SEM of at least three
separate experiments. Statistical analysis was carried out using
a t test, with significance set at p < 0.05.
Results
This investigation was based on the hypothesis that cur-
cuminoids could affect the survival of breast cancer cells,
inhibiting their proliferation. To evaluate our hypothesis and
explore the antitumor effects of curcuminoids on breast cancer
cells, we performed an in vitro study in which three breast
cancer cell lines were treated with increasing dosages of
curcuminoids (0, 12.5, 25, and 50 mM) over a period of 24
hours. The proliferation of cancer cells treated with curcu-
minoids was then determined using MTS. The results
summarized in Fig. 1A indicate a decrease in the survival and
proliferation of breast cancer cells following an increase in
dosage of curcuminoids. Moreover, the inhibition of prolifer-
ation was found to vary according to the type of breast cancer:
breast cancer cells from cell lines MDA-MB-231 and MDA-
MB-435S were more sensitive to the antiproliferative action
of curcuminoids than those from the MCF-7 cell line
following exposure to 25e50 mM curcuminoids for 24 hours.
To explore whether the anti-proliferative action of curcu-
minoids was the result of apoptosis or necrosis of the breast
cancer cells, we used the APOPercentage Apoptosis Assay kit
to identify the formation of apoptotic cells in the three breast
cancer cell lines following exposure to curcuminoids for 24
hours. The results of APOPercentage Apoptosis assay are
shown in Fig. 1B, in which the pink-colored deposits are
a positive indication of the existence of apoptotic cells.
Measuring the absorbance at 550 nm enabled quantification of
the apoptotic cells in each of the breast cancer cell lines. The
results summarized in Fig. 1C suggest that the increase in
apoptosis of the breast cancer cells was dose-dependent, such
that the higher the dose of curcuminoids (0, 12.5, 25, or
50 mM), the greater the extent of apoptosis (Fig. 1C). The
quantitative increase in induced apoptosis was observed in all
three cell lines. The data in Fig. 1C also suggest that,
following a fourfold increase in the dose of curcuminoids
(from 12.5 mM to 50 mM), induced apoptosis increased from
a twofold to a fourfold enhancement of activation over the
control (all data statistically significant at p < 0.05).
Fig. 2. Apoptosis assayed by measuring the reduction of mitochondrial
membrane potential (MMP) in human breast cancer cells produced by cur-
cuminoid treatment. (A) After rhodamine staining, MMP in the breast cancer
cells was determined by measuring the intensity of red fluorescence on fluo-
rescence microscopy. The results indicated that MMP was significantly
reduced after treatment with 25e50 mM curcuminoids compared to controls
(which were treated with 0 mM curcuminoids). (B) Apoptosis assayed by
staining with Annexin V-FITC and propidium iodide and examination under
a fluorescence microscopy after the breast cancer cell lines had been treated
with 25 mM curcuminoids.
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suggest that the dose-dependent inhibition of proliferation in
the breast cancer cells could be attributed to apoptosis induced
by treatment with curcuminoids.
We used rhodamine to investigate whether the mitochon-
drial membrane potential (MMP) in the breast cancer cells was
affected by treatment with curcuminoids. The results in
Fig. 2A indicate that the MMP of breast cancer cells was
reduced following treatment with curcuminoids (up to 50 mM),
which demonstrates that the degree to which MMP was
reduced depends on the dosage of curcuminoids to which the
breast cancer cells were exposed.
Curcuminoid-induced apoptosis was further evaluated by
staining the breast cancer cells with Annexin V-FITC and
propidium iodide following treatment with 25 mM curcumi-
noids. The apoptotic cells were then examined under a fluo-
rescence microscope, the results indicating that treatment with
curcuminoids induced apoptosis in breast cancer cells, as
shown in Fig. 2B.
The results shown in Figs. 1 and 2 led us to the conclusion
that the inhibition of proliferation in all three breast cancer cell
lines was the result of apoptosis induced by curcuminoids.
To characterize the kinetics involved in the uptake of cur-
cuminoids by the breast cancer cells, we developed a repro-
ducible HPLC method with a high degree of sensitivity to
quantify the level of curcuminoids taken up by the cancer cells
following treatment. Using the HPLC system under the
conditions outlined in the Methods section, the major
components of curcuminoids, curcumin (the principal
constituent), and DMC and bDMC (its demethoxylated
derivatives), yielded three well-defined chromatographic peaks
(Fig. 3A). Further analysis indicated that the area under the
peaks associated with curcumin yielded perfect linearity with
the concentrations of curcuminoids used in the treatment (with
a correlation coefficient of 0.96). These results were produced
from a series of six standard solutions containing curcumi-
noids in the concentration range 0e80 mM. Similar linearity
was also observed in the peak areas associated with DMC and
bDMC (with correlation coefficients of 0.9825 and 0.9608,
respectively; data not shown). These results indicate the
applicability of the HPLC method developed in this study for
quantitatively assaying curcumin and its demethoxylated
derivatives (DMC and bDMC).
This study also evaluated the efficiency and precision of the
extraction method developed for the recovery of curcumi-
noids. We analyzed the results of recovery obtained through
repeating the extraction of curcuminoids at three concentration
levels: high (50 mM), medium (25 mM), and low (12.5 mM).Apoptosis Assay kit. The kit identifies the apoptotic cells as the pink-colored
deposits in the cultures of human breast cancer cells (B) after exposure to an
increasing dose (0, 12.5, 25, and 50 mM) of curcuminoids for 24 hours. (C)
Bars represent the absorbance at a wavelength of 550 mm, which is
a measurement of the apoptotic cells in each of the breast cancer cell lines
(solid bars, MDA-MB-231 cells; hatched bars, MDA-MB-435S cells; open
bars, MCF-7 cells). Data are shown as the mean  SEM of at least three
independent experiments. * Difference from controls (treated with 0 mM
curcuminoids) is statistically significant at p < 0.05.We obtained samples from the culture medium as well as from
the pellets of breast cancer cells. The results indicate that the
proposed extraction method achieved recovery efficiency of
72.4  5.2%, 67.2  5.3%, and 63.9  4.1%, respectively, for
curcumin, DMC, and bDMC in the samples prepared from
culture medium, as well as 67.9  5.3%, 65.6  4.9%, and
62.5  4.3%, respectively, for curcumin, DMC, and bDMC in
the samples prepared from the cell pellets. These values of
Fig. 3. HPLC chromatogram of curcuminoids taken up by human breast cancer
cells and remaining in the culture medium used for cultivation of the breast
cancer cells. (A) Using the HPLC conditions and extraction method devel-
oped, the characteristic peaks for the major components of the curcuminoids
curcumin, demethoxycurcumin (DMC), and bisdemethoxycurcumin (bDMC)
could be well differentiated and quantitated. (B) A typical set of HPLC
chromatograms to illustrate the variation of the HPLC peaks for curcumin and
its demethoxylated derivatives (DMC and bDMC), recovered from the breast
cancer cells (of the MDA-MB-435S cell line) by the extraction method
developed, in proportion to the dose of curcuminoids added into the culture
medium for the 24-hour treatment of cancer cells.
Table 1
Cellular uptake of curcuminoids by human breast cancer cells and the recovery
of curcumin and its demethoxylated derivatives (DMC and bDMC) from
cancer cells.
Dose (mM) MDA-MB-231 Cells (mg/mg total protein)
Curcumin DMC bDMC
0 ND ND ND
12.5 3.39  0.06 ND ND
25 6.46  0.03 3.14  0.08 2.91  0.05
50 12.01  0.10 6.78  0.14 5.20  0.08
Dose (mM) MDA-MB-435S Cells (mg/mg total protein)
Curcumin DMC bDMC
0 ND ND ND
12.5 4.72  0.01 2.85  0.02 ND
25 7.60  0.04 4.38  0.06 2.75  0.03
50 14.68  0.19 7.40  0.13 4.52  0.10
Dose (mM) MCF-7 Cells (mg/mg total protein)
Curcumin DMC bDMC
0 ND ND ND
12.5 2.30  0.01 ND ND
25 6.16  0.02 2.24  0.03 ND
50 10.87  0.05 4.56  0.01 2.22  0.01
Data are the mean  SEM of at least three independent experiments.
bDMC ¼ bisdemethoxycurcumin; DMC ¼ demethoxycurcumin; ND ¼ non-
detectable.
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of curcumin, DMC, and bDMC recovered from the cancer
cells and culture medium in the cellular uptake studies re-
ported below.
To study the cellular uptake kinetics of curcuminoids by
human breast cancer cells, we determined the levels of cur-
cuminoids in the cancer cells (following treatment with cur-
cuminoids for 24 hours) using the celleliquid extraction
method outlined earlier. The curcuminoid remaining in the
culture medium was also extracted, using the liquideliquid
extraction method, also described earlier. Fig. 3B presentsa typical set of HPLC chromatograms for the curcuminoids
recovered from breast cancer cells. The results illustrate that
the HPLC analytical method effectively characterized the
specific peaks for curcumin and its demethoxylated derivatives
(DMC and bDMC), as obtained from samples prepared with
culture medium (Fig. 3A). Furthermore, these HPLC peaks
increased in height and area subsequent to an increase in the
dosage of curcuminoids to which the breast cancer cells were
exposed.
We calculated the recovery of curcumin, DMC, and bDMC
from the breast cancer cell lines from the peak areas in
Fig. 3B. The results summarized in Table 1 indicate that the
amounts of curcumin, DMC, and bDMC taken up by the breast
cancer cells in all three cell lines increased proportionally with
the dose of curcuminoids used in the treatment. In other
words, the higher the dose used, the greater the amount of
curcumin, DMC, and bDMC recovered from the cancer cell
pellets.
The data related to cellular uptake outlined in Table 1 also
suggest that the quantities of curcumin and its demethoxylated
derivatives taken up by the breast cancer cells varied according
to the cell line. This implies that the total amount of curcumi-
noids taken up by the breast cancer cells showed a cell line-
dependent trend: MDA-MB-435S >MDA-MB-231 >MCF-7.
To explore the chemoprotective potential of curcuminoids,
we investigated the relationship between the inhibition of
proliferation (Fig. 1A) [as well as the induction of apoptosis
(Fig. 1C)] and the cellular uptake profiles of curcumin and its
demethoxylated derivatives (Table 2). The results for the
inhibition of proliferation are shown in Fig. 4A and those for
the induction of apoptosis in Fig. 4B. According to the profiles
in Fig. 4A, a linear correlation exists between the inhibition of
survival/proliferation and the logarithm of the curcuminoids
recovered from the cancer cells. The same correlation was
Table 2
Relationship between antiproliferative the concentration of 50% inhibition
(IC50) and cellular level of curcuminoids in human breast cancer cells.
Human Breast Cancer Cell Lines
MDA-MB-231 MDA-MB-435S MCF-7
Anti-proliferation IC50 (mM) 17.31  1.12 25.13  0.87 45.47  1.61
Cellular curcuminoids level*
(mg/mg total protein)
4.30  0.46 7.65  0.89 9.96  0.97
Data are the mean  SEM of at least three independent experiments.
bDMC ¼ bisdemethoxycurcumin; DMC ¼ demethoxycurcumin; ND ¼ non-
detectable.
* Cellular level at IC50 value, which is calculated from the cellular levels (in
Table 1) for each of the cell lines.
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that the proliferation of breast cancer cells depends exponen-
tially on the amount of curcuminoids taken up by the cancer
cells. Further analysis indicates that the concentration of 50%
inhibition (IC50) values for the inhibition of proliferation are
related to the cellular level of curcuminoids recovered from
the cells of all three breast cancer cell lines.
By contrast, an increase in the induction of apoptosis in
breast cancer cells was observed following an increase in the
cellular level of curcuminoids (Fig. 4B). This observation
suggests that the induction of apoptosis is linearly dependent
upon the quantity of curcuminoids taken up by the cancerFig. 4. Correlation between the percentage of inhibition in breast cancer cells and
inhibition of the proliferation of breast cancer cells (data from Fig. 1A) and the loga
1). The linear correlation, which has a correction coefficient of greater th
ition ¼ Intercept e P log (cellular uptake of curcuminoids), where P ¼ e63.95 for
P ¼ e30.7 for MCF-7 (R2 ¼ 0.982). (B) A linear correlation existed between the le
and the amounts of curcuminoids taken up by the cancer cells (data from Table 1).
can be described by the following equation: A550 ¼ Intercept e R (cellular up
R ¼ 0.0059 for MDA-MB-435S (R ¼ 0.986), R2 ¼ 0.0062 for MCF-7 (R2 ¼ 0.99cells. The same linearity was observed in all three cell lines
studied.
Collectively, the data illustrated in Fig. 4A and B and Table 1
imply that the increase in the cellular uptake of curcuminoids
and their accumulation in the breast cancer cells could play an
important role in arrested growth and cell death.
Inhibition of cell proliferation and induction of apoptosis
are regarded as key strategies in the prevention of cancer [7].
The development of rapid, reliable, sensitive HPLC assay
methods to measure the cellular uptake of curcuminoids and
analyze the quantitative relationship with the proliferation and
apoptosis of cancer cells could be highly beneficial to
researchers in breast cancer therapy.
Discussion
This review presents an overview of the current in vitro and
in vivo data supporting the therapeutic benefits of curcumi-
noids in cancer treatment as well as the challenges concerning
their development as adjuvant chemotherapeutic agents [19].
The results collected in this series of studies using the cell
lines of breast adenocarcinoma and breast ductal carcinoma
(isolated from breast cancer patients) provide experimental
evidence that curcuminoids irreversibly induce the apoptosis
of breast cancer cells.curcuminoid uptake. (A) A linear correlation exists between the percentage of
rithmic amount of curcuminoids taken up by the cancer cells (data from Table
an 0.982, could be described by the following equation: % of inhib-
MDA-MB-231 (R2 ¼ 0.989), P ¼ e49.799 for MDA-MB-435S (R2 ¼ 0.991),
vel (A550) of induction of apoptosis of breast cancer cells (data from Fig. 1B)
The linear correlation, which has a correction coefficient of greater than 0.986,
take of curcuminoids), where R ¼ 0.0036 for MDA-MB-231 (R2 ¼ 0.996),
7).
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analytical methods developed in this study for the assay of
curcumin and its demethoxylated derivatives (DMC and
bDMC) have several advantages: (1) the short running time
(<15 minutes) required for the qualitative determination and
quantitative assay of curcumin and its demethoxylated deriv-
atives (DMC and bDMC) coexisting in the curcuminoids; (2)
a simple extraction procedure providing a highly efficient
recovery of curcumin and its demethoxylated derivatives from
cell cultures and culture medium; and (3) assays with a high
degree of sensitivity and good correlation. Moreover, the
proposed method outperforms other methods reported in the
literature with regard to sensitivity of detection [16e18,20].
Compared to the methodologies described previously, the
HPLC method developed in this study is faster, provides
greater sensitivity, accuracy, and reproducibility, and is more
easily standardized.
The proposed method is capable of providing a qualitative
and quantitative determination of curcuminoids in cells,
tissues, and organs for a wide range of research purposes and
preclinical or clinical applications in breast cancer therapy.
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